
Quarterly report 2025-Q3
added 10-24-2025
The Procter & Gamble Company Revenue 2011-2026 | PG
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue The Procter & Gamble Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 B | 84 B | 82 B | 80.2 B | 76.1 B | 71 B | 67.7 B | 66.8 B | 65.1 B | 65.3 B | 76.3 B | 83.1 B | 84.2 B | 83.7 B | 82.6 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.3 B | 65.1 B | 76.8 B |
Quarterly Revenue The Procter & Gamble Company
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.4 B | 19.8 B | 21.9 B | 21.7 B | 20.2 B | 21.4 B | 21.9 B | 20.1 B | 20.8 B | 20.6 B | 41.4 B | 19.4 B | 21 B | 20.3 B | 41.3 B | 18.1 B | 19.7 B | 19.3 B | 19.7 B | 19.3 B | 18.2 B | 17.8 B | 18.2 B | 17.8 B | 17.4 B | 16.7 B | 16.5 B | 16.3 B | 17.4 B | 16.7 B | 17.4 B | 16.7 B | 16.9 B | 16.5 B | 16.9 B | 16.5 B | 16.9 B | 16.5 B | 16.9 B | 16.5 B | 18.5 B | 18.8 B | 20.2 B | 20.8 B | 19.3 B | 18.8 B | 22.3 B | 21.2 B | 21.7 B | 20.3 B | 22.2 B | 20.7 B | 21.7 B | 21.5 B | 22.1 B | 21.9 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 41.4 B | 16.3 B | 20.1 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Household products industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Natura &Co Holding S.A.
NTCO
|
26.7 B | - | - | $ 9.02 B | - | |
|
Colgate-Palmolive Company
CL
|
20.4 B | $ 83.98 | -0.39 % | $ 67.9 B | ||
|
The Clorox Company
CLX
|
7.1 B | $ 103.39 | -1.67 % | $ 12.8 B | ||
|
Church & Dwight Co.
CHD
|
6.2 B | $ 95.03 | -0.41 % | $ 23.1 B | ||
|
e.l.f. Beauty
ELF
|
321 M | $ 65.62 | 0.75 % | $ 3.59 B | ||
|
Coty
COTY
|
5.89 B | $ 2.26 | 4.15 % | $ 1.97 B | ||
|
Helen of Troy Limited
HELE
|
1.91 B | $ 16.87 | 0.84 % | $ 388 M | ||
|
Inter Parfums
IPAR
|
1.49 B | $ 95.49 | 2.68 % | $ 3.07 B | ||
|
The Estée Lauder Companies
EL
|
14.3 B | $ 74.55 | 2.59 % | $ 26.8 B | ||
|
Kimberly-Clark Corporation
KMB
|
4.08 B | $ 96.6 | -0.7 % | $ 32.1 B | ||
|
LifeVantage Corporation
LFVN
|
229 M | $ 4.17 | 0.48 % | $ 51.1 M | ||
|
Hims & Hers Health
HIMS
|
2.35 B | $ 21.15 | 8.85 % | $ 4.76 B | ||
|
Mannatech, Incorporated
MTEX
|
132 M | $ 5.19 | -7.73 % | $ 9.68 M | ||
|
Nature's Sunshine Products
NATR
|
480 M | $ 26.75 | -0.67 % | $ 482 M | ||
|
Edgewell Personal Care Company
EPC
|
2.25 B | $ 22.2 | 1.42 % | $ 1.1 B | ||
|
Nu Skin Enterprises
NUS
|
1.73 B | $ 7.51 | -0.13 % | $ 370 M | ||
|
Newell Brands
NWL
|
7.2 B | $ 3.86 | -0.77 % | $ 1.61 B | ||
|
Acme United Corporation
ACU
|
197 M | $ 45.99 | 2.63 % | $ 174 M | ||
|
Unilever PLC
UL
|
50.5 B | $ 58.23 | -0.19 % | $ 132 B | ||
|
Spectrum Brands Holdings
SPB
|
2.81 B | $ 78.91 | -0.16 % | $ 2.03 B | ||
|
Revlon
REV
|
2.08 B | - | -4.41 % | $ 212 M | ||
|
United-Guardian
UG
|
10.5 M | $ 6.59 | 0.69 % | $ 30.3 M | ||
|
Dogness (International) Corporation
DOGZ
|
27.1 M | $ 1.26 | - | $ 42.5 M | ||
|
USANA Health Sciences
USNA
|
925 M | $ 18.17 | 0.33 % | $ 337 M |